American Oncology Network Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,329	1,279	1,150	943.75	724.74
Revenue Growth (YoY)	122.27%	11.27%	21.82%	30.22%	-
Cost of Revenue	1,260	1,196	1,054	865.79	658.64
Gross Profit	68.62	82.8	95.45	77.96	66.11
Selling, General & Admin	105.08	100.71	89.89	77.05	44.03
Other Operating Expenses	1.57	0.11	0.29	0.74	0.18
Operating Expenses	80.35	100.71	89.89	77.05	44.03
Operating Income	-65.26	-49.15	5.57	0.91	22.07
Interest Income	4.34	1.33	0.15	0.13	0.03
Interest Expense	6.63	6.42	3.42	1.42	1.12
Other Expense / Income	-58.07	-49.09	-1,026.93	-0.74	-0.18
Pretax Income	-72.62	-62.51	2.59	0.36	21.17
Income Tax	3.73	0.38	1,027	0.46	-0.78
Net Income	-13.2	-5.54	2.59	-0.11	21.95
Shares Outstanding (Basic)	8	7	10	10	10
Shares Outstanding (Diluted)	8	7	10	10	10
Shares Change	17976.75%	-29.87%	-	-	-
EPS (Basic)	-1.30	-0.83	0.27	-0.01	2.30
EPS (Diluted)	-1.30	-0.83	0.27	-0.01	2.30
Free Cash Flow	12.63	-30.4	-13.98	-34.66	25.02
Free Cash Flow Per Share	1.68	-4.55	-1.47	-3.64	2.63
Gross Margin	5.16%	6.47%	8.30%	8.26%	9.12%
Operating Margin	-4.91%	-3.84%	0.48%	0.10%	3.05%
Profit Margin	-0.99%	-0.43%	0.23%	-0.01%	3.03%
Free Cash Flow Margin	0.95%	-2.38%	-1.22%	-3.67%	3.45%
Effective Tax Rate	-	-	39653.77%	129.58%	-3.70%
EBITDA	-25.65	0.26	23.09	7.85	25.94
EBITDA Margin	-1.93%	0.02%	2.01%	0.83%	3.58%
Depreciation & Amortization	17.15	16.74	17.08	6.08	3.66
EBIT	-42.8	-16.48	6.01	1.77	22.28
EBIT Margin	-3.22%	-1.29%	0.52%	0.19%	3.07%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.